President Donald Trump and Health and Human Services Secretary Robert F. Kennedy Jr. on Monday announced an expansion of the Most Favored Nation drug pricing plan and confirmed that major pharmaceutical companies had signed on to the plan.Also present for the event were Centers for Medicare and Medicaid Services Administrator Dr. Mehmet Oz and Commerce Secretary Howard Lutnick.
“Today brings us to a total of 26 companies that have now made agreements with us. These agreements cover nine out of ten drugs that are used by Americans,” Kennedy said.
Trump has pursued voluntary agreements with major companies to keep drug prices for Americans in line with developing nations to end the trend of such firms pricing drugs higher in the U.S. to cover research costs.
Ben Whedon is the Chief Political Correspondent for Just the News. Follow him on X.
Trending
- Home sales fell in August as nation’s supply rises to highest level in a decade
- US crude oil prices pass $100 per barrel as Trump says war in Iran will end after midterms
- White House honors Charlie Kirk on one-year anniversary of his death
- Somaliland’s President Seeks Israeli Military Presence as Regional Threats Grow
- Cartel Drones Over the Rio Grande Valley Drop 75 Percent After Army Lasers Go Active
- Prime Minister Carney Pledges to Upend U.S. Conflict Negotiations, Announcing Intent to Advance Ukraine into NATO
- CNN Just Ran One of the Worst AI Puff Pieces We’ve Ever Seen in Our Lives About That “AI Actor” Tilly Northwood
- Rubio to Seek $45 Million for Ecuador to Tackle Drug Trafficking
